Analyst Research Report Snapshot

Title:

Aurobindo Pharma receives USFDA Approval for Cefadroxil Oral Suspension

Price:

$5.00

Provider:

News Bites Pty Limited

Date:

26 Apr 2013

Pages:

16

Type:

AcrobatPDF

Companies referenced:

ARBN.NS

Available for Immediate Download
Summary:

Aurobindo Pharma Ltd (NSE:AUROPHARMA), India's 16th largest pharmaceuticals company by market capitalisation, decreased Rs1.20 (or 0.6%) to close at Rs190.40. Compared with the BSE Sensex Index, which fell 120.1 points (or 0.6%) on the day, this was a relative price change of -0.01%. The volume w...

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.